← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $4.7M of United Therapeutics Corporation

Sold$4,669,918
$491.57Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Sep 24Copier in Sep 25
The stock from Fri, Sep 25 open, $474.04
+14.6%
S&P 500, same days
−0.3%

16 of 30 trading days so far, to the Oct 19 close.

Traded Wed, Sep 23. Filed Thu, Sep 24, 4:31 PM ET, after the close. Returns use the Sep 25 open and the Oct 19 close. Not investment advice.